Breaking News Instant updates and real-time market news.

CNC

Centene

$129.28

0.15 (0.12%)

, MOH

Molina Healthcare

$103.69

3.26 (3.25%)

06:14
07/10/18
07/10
06:14
07/10/18
06:14

Risk adjuster suspension positive for Centene and Molina, says Piper Jaffray

Centers for Medicare & Medicaid Services suspending risk adjusters for the health exchange will likely cost the government and consumers more, but it could be positive for Centene (CNC) and Molina Healthcare (MOH), Piper Jaffray analyst Sarah James tells investors in a research note. Both companies are in a net payable position for 2017 and not having to pay these funds would allow the plans to retain cash, the analyst adds. James also sees a positive read-through for UnitedHealth (UNH), Aetna (AET) and Cigna (CI). The analyst finds it most likely that CMS will seek to adjust the risk adjusters in the end rather than cancel the program, but she adds the agency only has a few weeks for them to sort this out, which she feels is not enough time.

CNC

Centene

$129.28

0.15 (0.12%)

MOH

Molina Healthcare

$103.69

3.26 (3.25%)

UNH

UnitedHealth

$253.68

2.99 (1.19%)

AET

Aetna

$187.52

1.25 (0.67%)

CI

Cigna

$173.21

1.08 (0.63%)

  • 17

    Jul

  • 24

    Jul

  • 01

    Aug

  • 02

    Aug

  • 21

    Aug

  • 23

    Oct

  • 14

    Dec

CNC Centene
$129.28

0.15 (0.12%)

06/28/18
CANT
06/28/18
NO CHANGE
CANT
Amazon deal not to materially impact managed care segment, says Cantor Fitzgerald
Following the announcement that Amazon (AMZN) is acquiring PillPack, Cantor Fitzgerald analyst Steven Halper notes that back in April, CNBC had reported that Walmart (WMT) and Amazon were both looking to acquire the company, with Walmart likely to pay under $1B for PillPack. At this juncture, the analyst is not worried about Amazon's entrance into the prescription market and does not expect a material impact on any of the companies he covers in the managed care segment. Halper reiterates an Overweight rating of Aetna (AET), Anthem (ANTM), Centene (CNC), UnitedHealth (UNH) and Wellcare (WCG). He keeps a Neutral rating on Humana (HUM).
07/09/18
JPMS
07/09/18
NO CHANGE
JPMS
CMS suspension could save Molina, Centene hundreds of millions, says JPMorgan
The Centers for Medicare and Medicaid Services confirmed Saturday that it will at least temporarily suspend the healthcare exchange risk adjustment program. If true, the immediate effect is that this Fall Molina Healthcare (MOH) and Centene (CNC) would avoid paying hundreds of millions of accrued payments related to 2017, JPMorgan analyst Gary Taylor tells investors in a research note. He notes that Molina would avoid $912M in payments and Centene $677M, according to their annual filings. On the other side, Anthem (ANTM) would not collect an expected $400M-$500M receivable, Taylor adds, citing his estimate. The analyst believes the longer-term effect of suspension "would be possibly additional significant disruption/withdrawals/rate hikes in the individual market for 2018-19." 19. If permanently dismantled, Taylor estimates Molina could book a one-time $350M after-tax gain related to 2017, Centene no gain and Anthem a $320M after tax loss. In terms of recurring earnings power exposure to exchanges, the analyst believes only Molina could materially benefit.
06/27/18
JPMS
06/27/18
DOWNGRADE
Target $106
JPMS
Neutral
Molina Healthcare downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Gary Taylor downgraded Molina Healthcare (MOH) to Neutral from Overweight, telling investors in a research note that he sees a high probability that Molina will retain its $2.2B 2020 Texas Medicaid contracts, but he does not like the downside risk heading into that Q3 re-procurement announcement. As Molina focuses on retaining existing businesses and improving its margin profile, he believes Centene (CNC) and WellCare (WCG) are better positioned to win new Medicaid contracts. Taylor raised his price target on Molina to $106 from $91.
06/18/18
BMOC
06/18/18
NO CHANGE
Target $150
BMOC
Outperform
Centene price target raised to $150 from $135 at BMO Capital
BMO Capital analyst Matt Borsch raised his price target on Centene to $150 and kept his Outperform rating after the company's Investor Day, saying its preliminary FY19 revenue guidance of $69B looks conservative given than half of the growth should come from a full year of Fidelis. The analyst adds that the target looks reasonable with added possibility of upside, while also noting his more positive view on Centene's improved visibility toward earnings drivers next year and beyond.
MOH Molina Healthcare
$103.69

3.26 (3.25%)

06/27/18
JPMS
06/27/18
UPGRADE
Target $287
JPMS
Overweight
WellCare upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Gary Taylor upgraded WellCare (WCG) to Overweight from Neutral and raised his 2019YE price target to $287 from $223, telling investors in a research note that while he has missed strong stock performance over the last two months, he thinks WellCare still has the opportunity to drive long-term investor value through organic growth, acquisitions and operational execution driving higher margins. This morning, Taylor also downgraded peer Molina Healthcare (MOH) to Neutral from Overweight.
06/27/18
JPMS
06/27/18
NO CHANGE
JPMS
Molina's Medicaid solutions sale to DXC negative for Conduent, says JPMorgan
JPMorgan analyst Tien-tsin Huang notes that Molina (MOH) announced its intent to sell its Medicaid Management System to DXC Technology (DXC) for a total purchase price of $220M. The analyst is encouraged with the deal as it strengthens DXC's positioning in the Medicare and Medicaid implementation segment, as he anticipates the combined company to serve 24 U.S. states/regions. However, Huang views the deal to be competitively negative for Conduent (CNDT), who implements MMIS for 10 states/regions in the U.S. The analyst reiterates an Overweight rating on DXC's shares and a Neutral rating on Conduent.
06/27/18
06/27/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Molina Healthcare (MOH) downgraded to Neutral from Overweight at JPMorgan with analyst Gary Taylor saying he sees a high probability that Molina will retain its $2.2B 2020 Texas Medicaid contracts, but he does not like the downside risk heading into that Q3 re-procurement announcement. 2. Bio-Techne (TECH) downgraded to Hold from Buy at Deutsche Bank with analyst Dan Leonard stating that he increasingly questions the durability of its organic sales growth. 3. Horizon Pharma (HZNP) downgraded to Neutral from Buy at Citi with analyst Liav Abraham saying he sees limited upside to valuation at current levels following the recent upward inflection in the share price. 4. NuVasive (NUVA) downgraded to Underperform from Neutral at BofA/Merrill with analyst Bob Hopkins stating that he is skeptical NuVasive can consistently drive high single digit revenue growth due to robotics momentum in the marketplace and lack of a differentiated product. 5. Wesco (WCC) downgraded to Sector Weight from Overweight at KeyBanc with analyst Steve Barger saying its recent inability to translate increasing sales to incremental margin is reflective of the more competitive electrical distribution market it serves. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
UNH UnitedHealth
$253.68

2.99 (1.19%)

07/05/18
CANT
07/05/18
NO CHANGE
Target $300
CANT
Overweight
UnitedHealth shares 'remain very attractive,' says Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper reiterates an Overweight rating on UnitedHealth with a $300 price target ahead of the company's Q2 results. The company kicks off the Q2 reporting season on July 17 and should report "strong" results, continuing the trend from Q1, Halper tells investors in a pre-earnings research note. The shares "remain very attractive," the analyst adds.
06/21/18
BMOC
06/21/18
NO CHANGE
Target $300
BMOC
Outperform
UnitedHealth price target raised to $300 from $285 at BMO Capital
BMO Capital analyst Matt Borsch raised his price target on UnitedHealth to $300 after its meeting with investors and a positive update on its current state of the business. The analyst contends that the company's advantage over competitors is stronger than it has ever been before as it widens its lead "in terms of product, innovation, technology, scope, and scale". Borsch keeps his Outperform rating on UnitedHealth, adding that the company could further benefit from competitors' distractions such as the pending CVS (CVS) - Aetna (AET) and Cigna (CI) -Express Scripts (ESRX) mergers.
06/25/18
LEHM
06/25/18
UPGRADE
Target $130
LEHM
Overweight
Quest Diagnostics upgraded to Overweight from Equal Weight at Barclays
As previously reported, Barclays analyst Jack Meehan upgraded Quest Diagnostics (DGX) to Overweight from Equal Weight and raised his price target to $130 from $120, telling investors in a research note that Quest has a "very favorable" risk-reward profile and current levels. Meehan contends that it "could be a big deal" that UnitedHealth (UNH) will share savings with preferred labs as volume shifts from high-cost settings, a first for the lab industry, and that his primary care physician survey indicates that both Quest and LabCorb (LH) should gain share as payor networks open. Additionally, Meehan says the "pieces are in place" for Quest to more meaningfully leverage its diagnostic data asset with customers. Commenting further on Top Pick LabCorp, Meehan believes industry themes that bode well for Quest also bode well for LabCorp.
AET Aetna
$187.52

1.25 (0.67%)

06/29/18
RBCM
06/29/18
NO CHANGE
Target $84
RBCM
Outperform
CVS Health price target lowered to $84 from $91 at RBC Capital
RBC Capital analyst George Hill lowered his price target on CVS Health Corp (CVS) to $84 after Amazon (AMZN) announced its entry into the pharmacy space with the acquisition of PillPack, even though he believes that the "stickiness of payer/pharmacy relationships, decreasing share of mail order, and PillPack's market share" will not cut margins in near to medium term. Hill keeps his Outperform rating on CVS, noting that it is better positioned to continue to grow its EBIT than Walgreens (WBA). The analyst also sees Amazon's entry into drug distribution raising the possibility of DOJ approval of CVS's Aetna (AET) acquisition.
07/09/18
SBSH
07/09/18
UPGRADE
Target $81
SBSH
Buy
CVS Health assumed to Buy from Neutral at Citi
Citi analyst Ralph Giacobbe upgraded CVS Health (CVS) to Buy after assuming coverage of the name. The analyst raised his price target for the shares to $81 from $68. While the execution of an integrated healthcare superstore post the pending Aetna (AET) acquisition may be a long way off, the concept will resonate with employers and individuals, Giacobbe tells investors in a research note. He believes deal integration and competitive Amazon (AMZN) risk are "somewhat overstated particularly in the context of heavily discounted valuation."
CI Cigna
$173.21

1.08 (0.63%)

06/13/18
LEER
06/13/18
NO CHANGE
LEER
AT&T, Time Warner approval positive for PBM-MDCO deals, says Leerink
Leerink analyst Ana Gupte says that the highly anticipated AT&T (T)-Time Warner (TWX) court decision is in favor of the companies and against the DoJ, "meaningfully increasing" the probability that the two vertical mega-mergers will close, namely Aetna (AET) and Express Scripts (ESRX), and CVS (CVS) and Cigna (CI).
06/13/18
DBAB
06/13/18
NO CHANGE
DBAB
CVS, Aetna deal on track to close in second half, says Deutsche Bank
After AT&T (T) won approval to acquire Time Warner (TWX), Deutsche Bank analyst Glen Santangelo continues to believe that CVS Health's (CVS) acquisition of Aetna (AET) is on track to close in the second half of 2018. He expects the favorable Time Warner ruling to further reduce the market spreads in both CVS, Aetna and Cigna (CI), Express Scripts (ESRX) from current levels. Shares of CVS represent a "compelling investment opportunity" at current valuation levels regardless of the regulatory outcome of the deal, Santangelo tells investors in a research note. He believes Cigna's acquisition of Express Scripts is also likely to close.
06/13/18
OPCO
06/13/18
NO CHANGE
OPCO
AT&T, Time Warner merger approval favorable for big healthcare deals, says Oppenheimer
Oppenheimer analyst Mohan Naidu notes that a federal judge approved AT&T's (T) purchase of Time Warner (TWX), without conditions, in a decision on a case brought by the DoJ in November, on insufficient proof of consumer or competitive harm, in what was widely considered a vertical merger. The closely watched trial was seen as a precedent case for CVS (CVS)-Aetna (AET) and Cigna (CI)-Express Scripts (ESRX), two vertical mergers in healthcare also currently under review by DoJ, he contends.

TODAY'S FREE FLY STORIES

03:05
07/23/18
07/23
03:05
07/23/18
03:05
General news
FX Update: The dollar remained on a softening track »

FX Update: The dollar…

AGIO

Agios Pharmaceuticals

$91.06

-0.23 (-0.25%)

, CELG

Celgene

$85.09

-0.26 (-0.30%)

20:07
07/22/18
07/22
20:07
07/22/18
20:07
Recommendations
Agios Pharmaceuticals, Celgene analyst commentary at Piper Jaffray »

Agios' Tibsovo…

AGIO

Agios Pharmaceuticals

$91.06

-0.23 (-0.25%)

CELG

Celgene

$85.09

-0.26 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 21

    Aug

SYNT

Syntel

$39.15

0.14 (0.36%)

, FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

19:25
07/22/18
07/22
19:25
07/22/18
19:25
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

SYNT

Syntel

$39.15

0.14 (0.36%)

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

PM

Philip Morris

$84.31

3.41 (4.22%)

RACE

Ferrari

$139.98

-2.65 (-1.86%)

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

NFLX

Netflix

$361.33

-2.81 (-0.77%)

TSLA

Tesla

$313.49

-6.85 (-2.14%)

SNE

Sony

$52.97

0.355 (0.67%)

AB

AllianceBernstein

$29.90

-0.05 (-0.17%)

BLK

BlackRock

$503.01

-1.42 (-0.28%)

BEN

Franklin Resources

$31.99

-0.28 (-0.87%)

IVZ

Invesco

$25.46

-0.245 (-0.95%)

LM

Legg Mason

$33.37

-0.13 (-0.39%)

TROW

T. Rowe Price

$119.87

-0.85 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 06

    Aug

  • 07

    Aug

  • 15

    Aug

  • 16

    Aug

  • 16

    Aug

INDB

Independent Bank

$88.10

6.45 (7.90%)

17:48
07/22/18
07/22
17:48
07/22/18
17:48
Upgrade
Independent Bank rating change at Keefe Bruyette »

Independent Bank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHLB

Berkshire Hills Bancorp

$41.40

0.45 (1.10%)

17:47
07/22/18
07/22
17:47
07/22/18
17:47
Downgrade
Berkshire Hills Bancorp rating change at Keefe Bruyette »

Berkshire Hills…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Acquired by T

$0.00

(0.00%)

, CMCSA

Comcast

$34.30

-0.61 (-1.75%)

17:14
07/22/18
07/22
17:14
07/22/18
17:14
Hot Stocks
Box Office Battle: 'Equalizer 2' beats 'Mamma Mia: Here We Go Again!' »

Sony's (SNE)…

TWX

Acquired by T

$0.00

(0.00%)

CMCSA

Comcast

$34.30

-0.61 (-1.75%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$52.97

0.355 (0.67%)

FOX

21st Century Fox

$45.69

-0.5 (-1.08%)

FOXA

21st Century Fox

$46.01

-0.54 (-1.16%)

LGF.A

Lionsgate

$24.88

-0.08 (-0.32%)

DIS

Disney

$111.48

-0.66 (-0.59%)

VIAB

Viacom

$27.49

-0.51 (-1.82%)

VIA

Viacom

$32.10

-0.3 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 07

    Aug

  • 09

    Aug

  • 09

    Aug

  • 09

    Aug

BGNE

BeiGene

$169.98

5.95 (3.63%)

16:43
07/22/18
07/22
16:43
07/22/18
16:43
Hot Stocks
BeiGene planning to pursue accelerated approval in U.S. of Zanubrutinib in WM »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$169.98

5.95 (3.63%)

16:40
07/22/18
07/22
16:40
07/22/18
16:40
Hot Stocks
BeiGene announces preliminary topline results of Hodgkin's Lymphoma trial »

BeiGene announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNT

Syntel

$39.15

0.14 (0.36%)

16:17
07/22/18
07/22
16:17
07/22/18
16:17
Earnings
Syntel reports preliminary Q2 EPS 49c, consensus 44c »

Reports preliminary Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 06

    Aug

  • 15

    Aug

  • 16

    Aug

SYNT

Syntel

$39.15

0.14 (0.36%)

16:13
07/22/18
07/22
16:13
07/22/18
16:13
Hot Stocks
Syntel enters definitive agreement to be acquired by Atos S.E. »

Syntel announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 06

    Aug

  • 15

    Aug

  • 16

    Aug

DDE

Dover Downs

$2.04

0.01 (0.49%)

16:11
07/22/18
07/22
16:11
07/22/18
16:11
Hot Stocks
Dover Downs to combine with Twin River Worldwide »

Dover Downs and Twin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWO

Two Harbors

$15.92

-0.05 (-0.31%)

, CYS

CYS Investments

$7.57

-0.025 (-0.33%)

13:36
07/22/18
07/22
13:36
07/22/18
13:36
Conference/Events
CYS Investments to host special shareholder meeting »

Special Shareholder…

TWO

Two Harbors

$15.92

-0.05 (-0.31%)

CYS

CYS Investments

$7.57

-0.025 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 08

    Aug

CYS

CYS Investments

$7.57

-0.025 (-0.33%)

, TWO

Two Harbors

$15.92

-0.05 (-0.31%)

13:34
07/22/18
07/22
13:34
07/22/18
13:34
Conference/Events
Two Harbors to host special shareholder meeting »

Special Shareholder…

CYS

CYS Investments

$7.57

-0.025 (-0.33%)

TWO

Two Harbors

$15.92

-0.05 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

JD

JD.com

$35.50

-1.37 (-3.72%)

13:28
07/22/18
07/22
13:28
07/22/18
13:28
Periodicals
JD.com plans move into Europe, Reuters reports »

JD.com's chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$191.29

-0.66 (-0.34%)

12:37
07/22/18
07/22
12:37
07/22/18
12:37
Periodicals
China aiming to supply Apple with OLED smartphone screens, WSJ says »

China's campaign to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

PZZA

Papa John's

$51.61

0.62 (1.22%)

12:30
07/22/18
07/22
12:30
07/22/18
12:30
Periodicals
Papa John's board to discuss 'poison pill,' WSJ reports »

Papa John's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$0.00

(0.00%)

, BAESY

BAE Systems

$0.00

(0.00%)

12:22
07/22/18
07/22
12:22
07/22/18
12:22
Periodicals
Airbus CEO says open to jet fighter merger with BAE Systems, Reuters reports »

The chief executive of…

EADSY

Airbus

$0.00

(0.00%)

BAESY

BAE Systems

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

12:17
07/22/18
07/22
12:17
07/22/18
12:17
Periodicals
Volkswagen parking cars due to new emissions testing bottlenecks, Reuters says »

Volkswagen is renting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$27.26

0.21 (0.78%)

12:11
07/22/18
07/22
12:11
07/22/18
12:11
Hot Stocks
KKR consortium proposes acquisition of LCY Chemical »

LCY Chemical and global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

PM

Philip Morris

$84.31

3.41 (4.22%)

, RACE

Ferrari

$139.98

-2.65 (-1.86%)

11:58
07/22/18
07/22
11:58
07/22/18
11:58
Hot Stocks
Philip Morris' non-executive board chairman to assume CEO role at Ferrari »

Philip Morris (PM) said…

PM

Philip Morris

$84.31

3.41 (4.22%)

RACE

Ferrari

$139.98

-2.65 (-1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

MDLZ

Mondelez

$42.46

0.21 (0.50%)

11:55
07/22/18
07/22
11:55
07/22/18
11:55
Hot Stocks
Mondelez conducts voluntary recall of certain Ritz Cracker sandwiches »

Mondelez Global announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ACN

Accenture

$166.47

-0.47 (-0.28%)

, EADSY

Airbus

$0.00

(0.00%)

04:55
07/22/18
07/22
04:55
07/22/18
04:55
Conference/Events
Farnborough International to hold an airshow »

Farnborough International…

ACN

Accenture

$166.47

-0.47 (-0.28%)

EADSY

Airbus

$0.00

(0.00%)

ATI

Allegheny Technologies

$26.65

0.08 (0.30%)

BAESY

BAE Systems

$0.00

(0.00%)

BDRBF

Bombardier

$0.00

(0.00%)

CAE

CAE

$20.96

0.17 (0.82%)

CW

Curtiss-Wright

$125.79

-0.12 (-0.10%)

DASTY

Dassault Systemes

$0.00

(0.00%)

ESLT

Elbit Systems

$118.98

0.64 (0.54%)

LMT

Lockheed Martin

$322.76

3.09 (0.97%)

BA

Boeing

$354.92

-0.57 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 02

    Aug

  • 06

    Aug

  • 16

    Aug

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

13:14
07/21/18
07/21
13:14
07/21/18
13:14
Hot Stocks
Fiat names Jeep head as CEO as Marchionne's health worsens »

In a statement, Fiat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RACE

Ferrari

$139.98

-2.65 (-1.86%)

, PM

Philip Morris

$84.31

3.41 (4.22%)

13:10
07/21/18
07/21
13:10
07/21/18
13:10
Hot Stocks
Ferrari to name former Philip Morris chairman as CEO »

The Board of Directors of…

RACE

Ferrari

$139.98

-2.65 (-1.86%)

PM

Philip Morris

$84.31

3.41 (4.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

, TM

Toyota

$131.87

0.11 (0.08%)

12:51
07/21/18
07/21
12:51
07/21/18
12:51
Periodicals
Amazon, others working to counter Trump's tariff plans, Reuters says »

Big companies in the…

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

TM

Toyota

$131.87

0.11 (0.08%)

AA

Alcoa

$40.32

-1.36 (-3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.